Adocia Archives

News and Trends 30 Sep 2019

Update: Mixed Results for Adocia as Legal Fight with Eli Lilly Comes to a Close

Update (30/09/2019): A long legal battle between Adocia and Eli Lilly over a fast-acting insulin treatment development deal has finished with mixed results for Adocia. Eli Lilly has now paid…

September 30, 2019 - 4 minutesmins - By Editorial Team

Best in Biotech 10 Jul 2019

The Top 10 Biotechs You’ll Find in Lyon

Lyon is one of the hotspots for biotech in Europe. Here are 10 of the most successful biotech companies in this beautiful French city. The second largest city in France…

July 10, 2019 - 6 minutesmins - By Clara Rodríguez Fernández

In Depth 11 Mar 2019

The Three Steps Needed to Fully Automate the Artificial Pancreas

New advances in diabetes research are making it possible to develop a fully automated insulin delivery system that can control blood sugar without any input from the patient. This so-called…

March 11, 2019 - 11 minutesmins - By Clara Rodríguez Fernández

News and Trends 6 Sep 2018

Insulin Combo Reduces After-Meal Sugar Spikes in Type 1 Diabetics

In the midst of a legal litigation with Eli Lilly, Adocia has released Phase 1 data showing its insulin combo can outperform Lilly’s fast-acting insulin in keeping sugar levels low…

September 6, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

Adocia Double Hormone Diabetes Treatment

News and Trends 16 Apr 2018

French Double-Hormone Diabetes Treatment to be Tested in Humans for the First Time

Adocia, a French biotech, will initiate a Phase I clinical study to test a diabetes treatment that maximizes the effect of two blood sugar-lowering hormones. Adocia will start a Phase I…

April 16, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 7 Dec 2017

French Biotech’s Type 1 Diabetes Candidate Ready to Battle it Out with Big Pharma

Adocia’s rapid-action insulin outperforms Novo Nordisk’s market approved treatment for type 1 diabetes during a Phase I study. Adocia specializes in new formulations of therapeutic proteins, particularly for the treatment…

December 7, 2017 - 3 minutesmins - By Alex Dale

News and Trends 21 Nov 2017

Can this French Biotech Make it Easier to Rescue People from Hypoglycemia?

Adocia's ready-to-use glucagon has proved to be safe in phase I trials. The company believes it can overthrow Novo Nordisk and Eli Lilly in rescuing severe hypoglycemia. Based in Lyon,…

November 21, 2017 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 27 Jan 2017

Bad News for Diabetics: Eli Lilly Abandons French Ultra-Rapid Insulin

Eli Lilly has decided to terminate its partnership with Adocia for the development of BioChaperone Lispro, an ultra-rapid insulin for diabetes. Despite results from 6 clinical studies indicating that Adocia's…

January 27, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

diabetes glucose chronic disease biotech pharma review

News and Trends 14 Jun 2016

Could this be the ‘Beginning of the end’ for Diabetes? Let’s Review.

Given the rates of diabetes reaching 'epidemic proportions', we figured it was time to have a better overview of biotech's progress in the field. With some serious advances having been…

June 14, 2016 - 9 minutesmins - By Dani Bancroft

News and Trends 9 Nov 2015

This French Biotech has a ‘Super-Insulin’ up its Diabetes Sleeve

Human insulin produced in Bacteria is already a miracle for Diabetes...but sometimes, it’s not as efficient as it could be. The French Biotech Adocia is developing a super-insulin and showed…

November 9, 2015 - 3 minutesmins - By Philip Hemme

News and Trends 1 Jul 2015

Is Adocia & Eli Lilly’s treatment the new diabetes blockbuster?

Adocia and Eli Lilly completed an impressive Phase Ib clinical trial evaluating BioChaperone Lispro, a treatment designed to accelerate insulin absorption. The study aimed to compare BioChaperone Lispro to Lilly’s…

July 1, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 20 Dec 2014

French Biotech Start-up Adocia signs Massive €464M Diabetes Deal with Eli Lilly

The French biotechnology company Adocia entered into an alliance with the US Eli Lilly on the co-development of an ultra-fast insulin to treat type 1 and type 2 diabetes. This…

December 20, 2014 - 2 minutesmins - By Philip Hemme

News and Trends 26 Aug 2014

Adocia launches a Phase III in India for its Diabetic Foot Ulcer treatment

Adocia announced today the initiation of a clinical Phase III study in India of BioChaperone PDGF-BB, the company’s innovative formulation of Platelet Derived Growth Factor (PDGF-BB) for the treatment of…

August 26, 2014 - 3 minutesmins - By Joachim Eeckhout

Report: new Frontiers in Vaccinology

Listen to our podcast

View all sectors A-Z

Register for the Webinar

View all companies A-Z

Find new scientific partnerships. Create a free IN-PART account

View all countries A-Z

Report: The European Biotech Startup Ecosystem

Subcribe to our newsletter

Learn more about Inova, the leading platform for biopharma partnering